Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma.

Translational lung cancer research·2026
Same author

Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Molecular Pathology of Lung Cancer.

Surgical pathology clinics·2026
Same author

Update on Pleural Epithelioid Mesothelioma: New Insights for Diagnosis and Patient Management.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype.

The Journal of clinical investigation·2025
Same author

A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

相关实验视频

Updated: Jul 21, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

在新辅助剂治疗的肺癌中病理反应评估.

Sanja Dacic1

  • 1Department of Pathology Yale School of Medicine, 200 So Frontage Street, EP2-607, New Haven, CT 06510, USA.

Surgical pathology clinics
|May 1, 2024
PubMed
概括

主要病理反应 (MPR) 和病理完整反应 (pCR) 是非小细胞肺癌试验的关键终点. 标准化他们对切除瘤的评估对于可靠的生存预测至关重要.

科学领域:

  • 在瘤学瘤学.
  • 病理学 病理学 病理学
  • 临床试验 临床试验

背景情况:

  • 主要病理反应 (MPR) 和病理完整反应 (pCR) 正在成为非小细胞肺癌 (NSCLC) 新辅助临床试验中的关键早期终点.
  • 这些指标有助于预测肺癌治疗中的患者生存结果.
  • MPR被定义为≤10%的可活性瘤,而pCR表示没有可活性瘤.

研究的目的:

  • 突出MPR和pCR在NSCLC新辅助药研究中的日益重要.
  • 引入国际肺癌研究协会 (IASLC) 关于标准化反应评估的建议.
  • 强调需要在新辅助疗法后对瘤反应进行一致的评估.

主要方法:

  • 对NSCLC新辅助药临床试验当前实践的审查.
  • 讨论IASLC对响应评估的多学科建议.
  • 专注于对切除的肺癌的大小和显微镜评估的标准化.

主要成果:

  • MPR和pCR越来越多地被用作NSCLC生存的替代标记.
  • 该IASLC提供了评估MPR和pCR的第一个标准化指南.
  • 标准化旨在提高临床试验结果的可靠性和可比性.
关键词:
肺癌是一种肺癌.新辅助剂是一种新辅助剂.病理反应 病理反应切除 切除 切除 切除

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K

相关实验视频

Last Updated: Jul 21, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.0K

结论:

  • 对MPR和pCR的标准化病理评估对于NSCLC新辅助试验至关重要.
  • 一致的评估可以改善早期终点和生存预测的解释.
  • 这些IASLC建议是协调肺癌研究中反应评估的重要一步.